The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study
Keyword(s):
Keyword(s):
2001 ◽
Vol 20
(3)
◽
pp. 197-202
◽
Keyword(s):
Keyword(s):
1982 ◽
Vol 138
(5)
◽
pp. 821-823
◽
1932 ◽
Vol 8
(2)
◽
pp. 170-181
◽